Hermansky-Pudlak syndrome synonyms

Hermansky-Pudlak syndrome (HPS) is a rare genetic disorder characterized by oculocutaneous albinism, a bleeding diathesis due to platelet storage pool deficiency, and lysosomal ceroid lipofuscinosis. While it is almost universally referred to as Hermansky-Pudlak syndrome in modern clinical literature, it has historically been known by various descriptive terms, including "delta-storage pool deficiency" and "albinism-hemorrhagic diathesis syndrome."

Why does Hermansky-Pudlak syndrome have multiple names?

The naming of Hermansky-Pudlak syndrome reflects the evolution of medical understanding regarding its complex, multi-system nature. Early literature frequently described the condition based solely on its most visible symptoms, leading to descriptive labels like "albinism with hemorrhagic diathesis." As researchers identified the underlying platelet abnormalities, the term "delta-storage pool deficiency" was frequently used in hematology journals. Furthermore, because Hermansky-Pudlak syndrome is a group of related genetic disorders (currently 11 known subtypes, HPS-1 through HPS-11), older medical records might occasionally refer to specific subtypes by their associated gene mutations rather than the umbrella term. Today, Hermansky-Pudlak syndrome is the preferred clinical nomenclature to ensure consistency across international medical databases.

What are the historical and alternative names for this condition?

When reviewing older medical records or international literature, you may encounter several terms that refer to the same clinical entity. The following list summarizes the historical and alternative names associated with Hermansky-Pudlak syndrome:

• Albinism-hemorrhagic diathesis syndrome: A classic descriptive name highlighting the two primary features.


• Delta-storage pool deficiency: A term focusing on the specific platelet function defect found in patients.


• HPS: The universally recognized medical abbreviation.


• Oculocutaneous albinism with platelet defect: A functional description often used in older textbooks.


• Ceroid-lipofuscinosis, oculocutaneous albinism: A term used to describe the late-onset systemic complications of the disease.

How is Hermansky-Pudlak syndrome classified in medical systems?

To avoid confusion, major medical classification systems have standardized the terminology for Hermansky-Pudlak syndrome. Using a standardized name is vital for insurance coding, clinical research, and patient coordination. In the International Classification of Diseases (ICD-10/11), it is indexed under rare disorders of pigmentation and platelet function. In the Online Mendelian Inheritance in Man (OMIM) database, it is cataloged under the entry #203300. Orphanet, the European reference portal for rare diseases, uses the primary name Hermansky-Pudlak syndrome (ORPHA:399) to unify all 11 genetic subtypes under a single diagnostic umbrella. At DiseaseMaps.org, where 8 community members have shared their journeys, we prioritize this standard nomenclature to ensure our members can connect regardless of their specific genetic subtype.

Next steps

• Consult with a clinical geneticist to confirm your specific HPS subtype, as this can influence clinical management and monitoring.


• Request that your medical records be updated to use the standard term "Hermansky-Pudlak syndrome" to ensure consistency across different specialists.


• Join the DiseaseMaps community to connect with other families navigating the complexities of this rare condition.


• Review the latest clinical trial information on the NIH GARD website to stay informed about potential therapeutic developments.

Medical disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases (GARD) Information Center - Hermansky-Pudlak syndrome.


• Orphanet: The portal for rare diseases and orphan drugs (ORPHA:399).


• Online Mendelian Inheritance in Man (OMIM) entry #203300.


• Hermansky-Pudlak Syndrome Network (HPS Network) official patient resources.